| 12/17/2025 | Robert W. Baird | Set Target | | $15.00 | |
| 12/16/2025 | Wells Fargo & Company | Boost Target | Overweight ➝ Overweight | $15.00 ➝ $20.00 | |
| 12/15/2025 | William Blair | Initiated Coverage | Outperform | | |
| 12/12/2025 | B. Riley | Boost Target | Buy ➝ Buy | $14.00 ➝ $17.00 | |
| 11/11/2025 | BTIG Research | Boost Target | Buy ➝ Buy | $11.00 ➝ $15.00 | |
| 11/11/2025 | UBS Group | Boost Target | Neutral ➝ Neutral | $10.50 ➝ $14.00 | |
| 11/11/2025 | B. Riley | Reiterated Rating | Buy ➝ Buy | $12.00 ➝ $14.00 | |
| 11/11/2025 | Robert W. Baird | Boost Target | Neutral ➝ Neutral | $8.00 ➝ $13.00 | |
| 11/5/2025 | KeyCorp | Upgrade | Sector Weight ➝ Overweight | $16.00 | |
| 10/29/2025 | Roth Capital | Set Target | Buy | $17.50 | |
| 10/29/2025 | Roth Capital | Upgrade | Strong-Buy | | |
| 10/15/2025 | UBS Group | Boost Target | Neutral ➝ Neutral | $8.00 ➝ $10.50 | |
| 10/8/2025 | Weiss Ratings | Reiterated Rating | Sell (D-) ➝ Sell (D-) | | |
| 9/27/2025 | Weiss Ratings | Reiterated Rating | Sell (D-) ➝ Sell (D-) | | |
| 9/15/2025 | B. Riley | Boost Target | Buy ➝ Buy | $9.00 ➝ $12.00 | |
| 9/10/2025 | BTIG Research | Boost Target | Buy ➝ Buy | $9.00 ➝ $11.00 | |
| 8/8/2025 | UBS Group | Boost Target | Neutral ➝ Neutral | $7.00 ➝ $8.00 | |
| 8/8/2025 | B. Riley | Reiterated Rating | Buy ➝ Buy | $8.00 ➝ $9.00 | |
| 7/17/2025 | B. Riley | Initiated Coverage | Buy | $8.00 | |
| 7/16/2025 | B. Riley | Upgrade | Strong-Buy | | |
| 5/9/2025 | UBS Group | Boost Target | Neutral ➝ Neutral | $6.00 ➝ $7.00 | |
| 2/26/2025 | UBS Group | Lower Target | Neutral ➝ Neutral | $10.00 ➝ $9.00 | |
| 12/17/2024 | Northland Securities | Boost Target | Outperform ➝ Outperform | $6.50 ➝ $12.50 | |
| 12/9/2024 | Wells Fargo & Company | Upgrade | Equal Weight ➝ Overweight | $4.00 ➝ $15.00 | |
| 11/5/2024 | UBS Group | Boost Target | Neutral ➝ Neutral | $3.00 ➝ $3.25 | |
| 9/16/2024 | Northland Capmk | Upgrade | Strong-Buy | | |
| 9/16/2024 | Northland Securities | Initiated Coverage | Outperform | $6.00 | |
| 8/7/2024 | Robert W. Baird | Lower Target | Neutral ➝ Neutral | $4.00 ➝ $3.50 | |
| 8/7/2024 | Wedbush | Lower Target | Outperform ➝ Outperform | $4.50 ➝ $4.00 | |
| 5/8/2024 | Wedbush | Boost Target | Outperform ➝ Outperform | $3.00 ➝ $4.50 | |
| 5/8/2024 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $2.00 ➝ $4.00 | |
| 5/8/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $6.00 | |
| 4/12/2024 | UBS Group | Boost Target | Neutral ➝ Neutral | $2.30 ➝ $3.70 | |
| 3/1/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $6.00 | |
| 1/4/2024 | Robert W. Baird | Reiterated Rating | Outperform ➝ Neutral | $3.25 ➝ $2.75 | |
| 11/9/2023 | Morgan Stanley | Boost Target | Equal Weight ➝ Equal Weight | $1.50 ➝ $2.50 | |
| 11/8/2023 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $6.00 | |
| 10/23/2023 | BMO Capital Markets | Lower Target | Market Perform ➝ Market Perform | $6.00 ➝ $5.50 | |
| 8/9/2023 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $6.00 | |
| 8/9/2023 | Piper Sandler | Boost Target | | $2.00 ➝ $3.00 | |
| 8/9/2023 | Robert W. Baird | Boost Target | | $2.75 ➝ $3.25 | |
| 6/29/2023 | Bank of America | Upgrade | Underperform ➝ Buy | $1.00 ➝ $1.85 | |
| 3/2/2023 | Credit Suisse Group | Lower Target | Neutral | $4.00 ➝ $3.50 | |
| 3/1/2023 | Needham & Company LLC | Reiterated Rating | Buy | $6.00 | |
| 3/1/2023 | Piper Sandler | Lower Target | Neutral | $3.00 ➝ $2.00 | |
| 3/1/2023 | Robert W. Baird | Lower Target | Outperform | $3.75 ➝ $2.75 | |
| 2/17/2023 | Needham & Company LLC | Reiterated Rating | Buy | $6.00 | |
| 1/6/2023 | Wells Fargo & Company | Downgrade | Overweight ➝ Equal Weight | $5.00 ➝ $2.00 | |
| 11/15/2022 | BTIG Research | Lower Target | | $3.00 | |
| 11/9/2022 | Wells Fargo & Company | Lower Target | Overweight | $8.00 ➝ $5.00 | |
| 11/9/2022 | Robert W. Baird | Lower Target | | $6.00 ➝ $3.75 | |
| 11/9/2022 | Raymond James Financial | Downgrade | Outperform ➝ Market Perform | | |
| 10/18/2022 | Piper Sandler | Lower Target | Neutral | $4.00 ➝ $3.00 | |
| 8/15/2022 | BTIG Research | Lower Target | | $7.00 | |
| 8/12/2022 | Cowen | Downgrade | Outperform ➝ Market Perform | $14.00 ➝ $3.00 | |
| 8/12/2022 | Cowen | Downgrade | Outperform ➝ Market Perform | $14.00 ➝ $3.00 | |
| 8/10/2022 | Wedbush | Lower Target | | $10.00 ➝ $5.00 | |
| 8/10/2022 | Needham & Company LLC | Lower Target | Buy | $10.00 ➝ $6.00 | |
| 8/10/2022 | Wells Fargo & Company | Lower Target | Overweight | $15.00 ➝ $8.00 | |
| 8/10/2022 | Credit Suisse Group | Lower Target | Neutral | $8.00 ➝ $4.00 | |
| 8/10/2022 | Morgan Stanley | Lower Target | Equal Weight | $10.00 ➝ $4.00 | |
| 8/10/2022 | Bank of America | Downgrade | Buy ➝ Underperform | $7.00 ➝ $2.75 | |
| 7/22/2022 | Piper Sandler | Reiterated Rating | Neutral | $4.00 | |
| 7/20/2022 | KeyCorp | Initiated Coverage | Sector Weight ➝ Sector Weight | | |
| 7/19/2022 | B. Riley | Set Target | | $3.00 | |
| 6/29/2022 | Raymond James Financial | Initiated Coverage | Outperform | $14.00 ➝ $9.00 | |
| 6/28/2022 | Stifel Nicolaus | Lower Target | | $6.00 ➝ $4.00 | |
| 6/8/2022 | Robert W. Baird | Lower Target | Outperform | $12.00 ➝ $6.00 | |
| 5/17/2022 | Needham & Company LLC | Reiterated Rating | Buy | $10.00 | |
| 5/11/2022 | Needham & Company LLC | Lower Target | | $25.00 ➝ $10.00 | |
| 5/11/2022 | B. Riley | Lower Target | | $9.00 ➝ $5.00 | |
| 3/29/2022 | Credit Suisse Group | Downgrade | Outperform ➝ Neutral | $15.00 ➝ $8.00 | |
| 3/22/2022 | UBS Group | Lower Target | Neutral | $17.00 ➝ $9.00 | |
| 3/17/2022 | Jefferies Financial Group | Initiated Coverage | Buy | $13.00 | |
| 2/24/2022 | Bank of America | Lower Target | Buy | $22.00 ➝ $18.00 | |
| 2/24/2022 | Wells Fargo & Company | Lower Target | Overweight | $19.00 ➝ $15.00 | |
| 2/24/2022 | Stifel Nicolaus | Lower Target | Hold | $15.00 ➝ $12.00 | |
| 2/24/2022 | Wedbush | Lower Target | Outperform | $21.00 ➝ $14.00 | |
| 2/24/2022 | Morgan Stanley | Lower Target | Equal Weight | $18.00 ➝ $17.00 | |
| 2/24/2022 | Raymond James Financial | Lower Target | Outperform | $19.00 ➝ $18.00 | |
| 2/24/2022 | Credit Suisse Group | Lower Target | Outperform | $24.00 ➝ $15.00 | |
| 2/24/2022 | Piper Sandler | Lower Target | Overweight | $21.00 ➝ $18.00 | |
| 1/26/2022 | B. Riley | Lower Target | | $12.00 ➝ $9.00 | |
| 1/25/2022 | Needham & Company LLC | Lower Target | | $35.00 ➝ $25.00 | |
| 1/20/2022 | KeyCorp | Lower Target | Overweight | $20.00 ➝ $16.00 | |
| 1/7/2022 | B. Riley | Lower Target | | $15.00 ➝ $12.00 | |
| 1/4/2022 | Wedbush | Upgrade | Neutral ➝ Outperform | $16.00 ➝ $21.00 | |
| 12/2/2021 | UBS Group | Downgrade | Buy ➝ Neutral | $17.00 | |
| 11/9/2021 | Cowen | Lower Target | Outperform | $23.00 ➝ $19.00 | |
| 11/9/2021 | Stifel Nicolaus | Boost Target | Hold | $15.00 ➝ $16.00 | |
| 11/9/2021 | Morgan Stanley | Lower Target | Equal Weight | $23.00 ➝ $21.00 | |
| 11/9/2021 | BTIG Research | Upgrade | Neutral ➝ Buy | $21.00 | |
| 11/9/2021 | Piper Sandler | Boost Target | Overweight | $20.00 ➝ $21.00 | |
| 10/26/2021 | Raymond James Financial | Upgrade | Market Perform ➝ Outperform | $19.00 | |
| 10/19/2021 | Stifel Nicolaus | Reiterated Rating | Hold | | |
| 10/5/2021 | KeyCorp | Lower Target | Overweight | $32.00 ➝ $20.00 | |
| 10/4/2021 | Wedbush | Initiated Coverage | Neutral | $14.00 | |
| 9/3/2021 | Needham & Company LLC | Initiated Coverage | Buy | $35.00 | |
| 8/10/2021 | Needham & Company LLC | Reiterated Rating | Buy | $35.00 | |
| 8/10/2021 | Robert W. Baird | Lower Target | Outperform | $27.00 ➝ $24.00 | |
| 8/10/2021 | Wells Fargo & Company | Lower Target | Overweight | $35.00 ➝ $28.00 | |
| 8/10/2021 | Morgan Stanley | Lower Target | Equal Weight | $25.00 ➝ $23.00 | |
| 7/21/2021 | Bank of America | Upgrade | Neutral ➝ Buy | $26.00 | |
| 7/8/2021 | BTIG Research | Reiterated Rating | Hold | | |
| 7/7/2021 | Needham & Company LLC | Initiated Coverage | Buy | $35.00 | |
| 5/17/2021 | BTIG Research | Reiterated Rating | Buy ➝ Neutral | | |
| 5/11/2021 | BTIG Research | Downgrade | Buy ➝ Neutral | | |
| 3/1/2021 | Raymond James Financial | Reiterated Rating | Outperform ➝ Market Perform | | |
| 2/23/2021 | Morgan Stanley | Boost Target | Equal Weight | $17.00 ➝ $25.00 | |
| 2/23/2021 | BTIG Research | Boost Target | Buy | $27.00 ➝ $32.00 | |
| 2/23/2021 | Cowen | Boost Target | Positive ➝ Outperform | $18.00 ➝ $29.00 | |
| 2/23/2021 | Raymond James Financial | Downgrade | Outperform ➝ Market Perform | | |
| 2/16/2021 | Piper Sandler | Boost Target | | $25.00 ➝ $33.00 | |
| 1/22/2021 | KeyCorp | Boost Target | Overweight | $21.00 ➝ $32.00 | |
| 1/15/2021 | Morgan Stanley | Boost Target | Equal Weight | $16.00 ➝ $17.00 | |
| 1/15/2021 | B. Riley | Boost Target | Neutral | $13.00 ➝ $26.00 | |
| 1/15/2021 | Wells Fargo & Company | Boost Target | Overweight | $25.00 ➝ $32.00 | |
| 1/11/2021 | Stifel Nicolaus | Downgrade | Buy ➝ Hold | $22.00 | |
| 1/4/2021 | Piper Sandler | Boost Target | Overweight | $19.00 ➝ $25.00 | |
| 12/22/2020 | Wells Fargo & Company | Boost Target | Overweight | $20.00 ➝ $25.00 | |
| 12/21/2020 | Robert W. Baird | Initiated Coverage | Outperform | $23.00 | |